• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDZ 结合激酶在卵巢癌中作为潜在的预后和诊断生物标志物的作用。

The Role of PDZ Binding Kinase as a Potential Prognostic and Diagnostic Biomarker in Ovarian Cancer.

机构信息

Department of Obstetrics & Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.

Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Shenyang, China.

出版信息

Cancer Biother Radiopharm. 2022 Sep;37(7):569-579. doi: 10.1089/cbr.2020.4249. Epub 2021 Mar 31.

DOI:10.1089/cbr.2020.4249
PMID:33794097
Abstract

As one of the three malignant genital tumors, mortality in women with ovarian cancer is consistently high worldwide. It is of great importance to find prognostic markers for diagnosis and treatment of ovarian cancer. In this study, the authors utilized the bioinformatics analysis to identify the potential key genes to reveal the potential mechanism for ovarian cancer. The authors used the gene expression profile (GSE14407) to perform differentially expressed gene (DEG) analysis and the weighted gene co-expression network analysis. They selected the key module and performed the gene ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis for the genes in the hub module. Then they screened the key genes in the hub module, and further validated their expression level. A total of 3124 DEGs were detected after differential gene expression analysis; of these, 433 were upregulated genes and 2691 were downregulated genes. The authors selected the brown module that is significantly associated with the gene expression. Then they selected 30 hub genes from the protein-protein interaction network. The authors identified the PDZ binding kinase () as the prognosis-associated hub gene whose expression was significantly high in the ovarian cancer tissue. The bioinformatics analysis for the DEGs could be important to understand the pathogenesis for ovarian cancer. In this study, is identified as a potential marker that might improve the understanding of the molecular mechanism and the diagnosis level for ovarian cancer.

摘要

作为三大恶性生殖系统肿瘤之一,全球范围内卵巢癌患者的死亡率一直居高不下。寻找用于卵巢癌诊断和治疗的预后标志物非常重要。在本研究中,作者利用生物信息学分析来识别潜在的关键基因,以揭示卵巢癌的潜在机制。

作者使用基因表达谱(GSE14407)进行差异表达基因(DEG)分析和加权基因共表达网络分析。他们选择关键模块,并对枢纽模块中的基因进行基因本体(GO)注释和京都基因与基因组百科全书(KEGG)通路富集分析。然后,他们筛选了枢纽模块中的关键基因,并进一步验证了其表达水平。

通过差异基因表达分析共检测到 3124 个 DEG;其中,上调基因 433 个,下调基因 2691 个。作者选择与基因表达显著相关的棕色模块。然后,他们从蛋白质-蛋白质相互作用网络中选择了 30 个枢纽基因。作者鉴定出 PDZ 结合激酶()作为与卵巢癌组织中表达显著升高相关的预后相关枢纽基因。

对 DEG 的生物信息学分析对于理解卵巢癌的发病机制可能很重要。在本研究中,确定为一种潜在的标志物,可能有助于提高对卵巢癌分子机制和诊断水平的认识。

相似文献

1
The Role of PDZ Binding Kinase as a Potential Prognostic and Diagnostic Biomarker in Ovarian Cancer.PDZ 结合激酶在卵巢癌中作为潜在的预后和诊断生物标志物的作用。
Cancer Biother Radiopharm. 2022 Sep;37(7):569-579. doi: 10.1089/cbr.2020.4249. Epub 2021 Mar 31.
2
Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.利用生物信息学分析和实验鉴定与卵巢癌预后相关的分子标志物。
J Cell Physiol. 2019 Jul;234(7):11023-11036. doi: 10.1002/jcp.27926. Epub 2019 Jan 11.
3
Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.卵巢癌中枢纽基因和治疗药物的筛选的综合生物信息学分析。
J Ovarian Res. 2020 Jan 27;13(1):10. doi: 10.1186/s13048-020-0613-2.
4
Four genes relevant to pathological grade and prognosis in ovarian cancer.与卵巢癌病理分级和预后相关的四个基因。
Cancer Biomark. 2020;29(2):169-178. doi: 10.3233/CBM-191162.
5
Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.卵巢上皮性癌差异表达基因的数据挖掘:精准医学的启示。
Curr Top Med Chem. 2021 Oct 5;21(14):1285-1300. doi: 10.2174/1568026621666210708093649.
6
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.生物信息学分析:ZFHX4 与卵巢癌的转移和不良预后相关。
J Ovarian Res. 2022 Aug 1;15(1):90. doi: 10.1186/s13048-022-01024-x.
7
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.miR-182 在卵巢癌中的预后价值及潜在通路信号分析:基于基因表达综合数据库(GEO)和生物信息学分析的研究。
J Ovarian Res. 2019 Nov 8;12(1):106. doi: 10.1186/s13048-019-0580-7.
8
Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.基于加权基因共表达网络分析鉴定高级别浆液性卵巢癌的枢纽基因
Med Sci Monit. 2020 Mar 17;26:e922107. doi: 10.12659/MSM.922107.
9
Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.运用综合生物信息学方法鉴定和分析与卵巢上皮性癌相关的基因。
PLoS One. 2021 Jun 18;16(6):e0253136. doi: 10.1371/journal.pone.0253136. eCollection 2021.
10
Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.整合生物信息学分析鉴定上皮性卵巢癌的关键分子标志物。
Taiwan J Obstet Gynecol. 2021 Nov;60(6):983-994. doi: 10.1016/j.tjog.2021.09.007.

引用本文的文献

1
Comparative Efficacy of Tumor Microenvironment-responsive Nanotherapeutics Targeting PSD95/Discs-large/ZO-1 Binding Kinase in Different Histological Subgroups of Medulloblastoma.靶向髓母细胞瘤不同组织学亚组中PSD95/盘状大蛋白/紧密连接蛋白1结合激酶的肿瘤微环境响应性纳米疗法的比较疗效
Int J Med Sci. 2024 Nov 11;21(15):3018-3033. doi: 10.7150/ijms.97992. eCollection 2024.
2
An in-silico approach leads to explore six genes as a molecular signatures of lung adenocarcinoma.一种计算机模拟方法用于探索六个基因作为肺腺癌的分子特征。
Am J Cancer Res. 2023 Mar 15;13(3):727-757. eCollection 2023.